Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TerraSante is a biotechnology company focused on the discovery of novel therapeutic compounds from the soil microbiome. The company utilizes a proprietary platform to access the genetic potential of the unculturable majority of microorganisms found in nature, often referred to as biological dark matter. By applying advanced metagenomics and synthetic biology, TerraSante identifies unique small molecules and natural products with potential applications in oncology, immunology, and infectious diseases. Led by industry veterans with expertise in microbial genomics, the company aims to translate environmental biological diversity into breakthrough medicines for unmet clinical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TerraSante.